Effects of vaccination with F-strain Mycoplasma gallisepticum on egg production and quality parameters of commercial layer hens previously vaccinated with 6/85-strain Mycoplasma gallisepticum

• Published in: Poultry science 2010-03, Vol.89 (3), p.501-504
• Main Authors: Leigh, S.A, Branton, S.L, Evans, J.D, Collier, S.D, Peebles, E.D
• Format: Article
• Language: English
• Subjects: adverse effects; animal age; animal pathogenic bacteria; Animals; Bacterial Vaccines - administration & dosage; Bacterial Vaccines - immunology; Chickens; egg production; egg quality; egg shell quality; egg weight; Female; Haugh units; laying hens; live vaccines; Mycoplasma gallisepticum; Mycoplasma gallisepticum - classification; Mycoplasma Infections - prevention & control; Mycoplasma Infections - veterinary; Poultry Diseases - prevention & control; strain differences; strains; temporal variation; Vaccination; vaccine strains
• ISSN: 0032-5791; 1525-3171
• DOI: 10.3382/ps.2009-00519

This study was conducted to determine the effect of overlaying (revaccinating) F-strain Mycoplasma gallisepticum at 22 or 45 wk of age on commercial leghorn hens previously vaccinated with 6/85-strain M. gallisepticum at 10 wk of age. The treatment groups included unvaccinated hens (group 1), hens receiving 6/85-strain M. gallisepticum only (group 2), and hens receiving 6/85-strain M. gallisepticum followed by F-strain M. gallisepticum at either 22 (group 3) or 45 (group 4) wk of age. There was no significant effect on egg production or egg size distribution between any of the treatment groups, unlike previous studies looking at F-strain vaccination only. Egg quality parameters, including eggshell strength, Haugh unit score, and blood-meat spot were similar between the different treatment groups. There was a difference in the rate of pimpling at postpeak production for the treatment group receiving F-strain M. gallisepticum at 22 wk of age, consistent with previously published results. This work suggests that hens previously vaccinated with 6/85-strain M. gallisepticum can be safely revaccinated with F-strain M. gallisepticum to increase protection from field strains while ameliorating the adverse effects associated with F-strain M. gallisepticum vaccination in layers post onset of lay.